1. Home
  2. NGL vs IMCR Comparison

NGL vs IMCR Comparison

Compare NGL & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NGL ENERGY PARTNERS LP

NGL

NGL ENERGY PARTNERS LP

HOLD

Current Price

$11.57

Market Cap

1.4B

Sector

Utilities

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$30.25

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NGL
IMCR
Founded
1940
2008
Country
United States
United Kingdom
Employees
569
N/A
Industry
Natural Gas Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.7B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
NGL
IMCR
Price
$11.57
$30.25
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$61.82
AVG Volume (30 Days)
230.3K
351.7K
Earning Date
02-03-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.39
EPS
N/A
N/A
Revenue
N/A
$249,428,000.00
Revenue This Year
N/A
$14.39
Revenue Next Year
N/A
$8.19
P/E Ratio
$366.01
N/A
Revenue Growth
N/A
43.05
52 Week Low
$2.64
$23.15
52 Week High
$13.00
$40.71

Technical Indicators

Market Signals
Indicator
NGL
IMCR
Relative Strength Index (RSI) 50.19 36.52
Support Level $11.18 N/A
Resistance Level $13.00 $34.86
Average True Range (ATR) 0.53 1.44
MACD -0.08 -0.24
Stochastic Oscillator 31.75 6.80

Price Performance

Historical Comparison
NGL
IMCR

About NGL NGL ENERGY PARTNERS LP

NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: